Case report review suggests LAI paliperidone stabilizes behavior in a 9-year-old with TBI over two years
Long-acting shots help a boy control severe brain injury rage
This case report review describes a 9-year-old boy with severe traumatic brain injury and posttraumatic confusional state treated with long-…
A boy with severe brain injury rage found calm after months of failed pills, showing long-acting shots could help when daily medicine fails
Methylphenidate-treated children with ADHD show wider fQRS-T angles compared to healthy controls in a cross-sectional study.
Could long-term ADHD medication be linked to subtle heart electrical changes?
This single-center, retrospective cross-sectional study compared 75 children and adolescents with DSM-5 ADHD receiving continuous methylphen…
Children taking long-term ADHD medication showed wider heart electrical angles linked to natural inflammation rather than the drug itself.
Early childhood temperament deviations linked to higher ADHD risk in Norwegian cohort study
Early childhood temperament patterns linked to later ADHD risk in large Norwegian study
A large Norwegian cohort study of over 50,000 children found that deviations from expected temperament development trajectories at ages 1.5,…
Children with unusual early temperament patterns face higher ADHD risk later in life, according to a large Norwegian study of over 50,000 ki…
Methylphenidate plus iron shows earlier response in children with severe ADHD and iron deficiency
Iron supplements with ADHD medication may help children with both conditions
A small RCT of 50 children with severe ADHD and iron deficiency in Bangladesh compared methylphenidate plus iron to methylphenidate alone ov…
Adding iron supplements to ADHD medication helped children with both conditions improve symptoms faster than medication alone.
FDA Approves Methylphenidate Hydrochloride Extended-Release Tablets for ADHD and Narcolepsy
The FDA has approved a new, longer-acting generic version of a common ADHD and narcolepsy medication.
The FDA has approved methylphenidate hydrochloride extended-release tablets for the treatment of Attention Deficit Hyperactivity Disorder (A…
The FDA approved a new generic ADHD and narcolepsy medicine that works for about 8 hours, offering a longer-lasting option for patients 6 ye…